Is therapy with cytostatics obsolete in hairy-cell leukemia?
Franchi
F
F
Seminara
P
P
Codacci-Pisanelli
G
G
Bianco
P
P
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D006801:Humans; D015255:Idarubicin / Q000008:administration & dosage; D007155:Immunologic Factors / Q000627:therapeutic use*; D016898:Interferon-alpha / Q000627:therapeutic use*; D007943:Leukemia, Hairy Cell / Q000188:drug therapy* / Q000628:therapy; D008297:Male; D008875:Middle Aged; D012074:Remission Induction; D016879:Salvage Therapy; D014747:Vinblastine / Q000008:administration & dosage
D007155:Immunologic Factors; D016898:Interferon-alpha; D014747:Vinblastine; D015255:Idarubicin